CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY
TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
(Address, including zip code, and telephone number, including area code, of registrant’s principal
executive offices)
COMMON STOCK, PAR VALUE $.001; COMMON STOCK
SUBSCRIPTION WARRANTS
(Title of each class of securities covered by this Form)
NONE
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i)
x
Rule 12h-3(b)(1)(i)
¨
Rule 12g-4(a)(1)(ii)
¨
Rule 12h-3(b)(1)(ii)
¨
Rule 12g-4(a)(2)(i)
¨
Rule 12h-3(b)(2)(i)
¨
Rule 12g-4(a)(2)(ii)
¨
Rule 12h-3(b)(2)(ii)
¨
Rule 15d-6
¨
Approximate number of holders of record as of the certification or
notice date: Holders of common stock: 0; Holders of Warrants: 25
Pursuant to the requirements of the Securities
Exchange Act of 1934, Nexell Therapeutics Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
